Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001125282-06-001844
Filing Date
2006-03-28
Accepted
2006-03-28 16:16:57
Documents
12
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT b412199_10k.htm 10-K 1313097
2 GRAPHIC emptybox.gif GRAPHIC 861
3 GRAPHIC tickedbox.gif GRAPHIC 897
4 EXHIBIT 10.15 b412199ex10_15.htm EX-10.15 107750
5 EXHIBIT 10.16 b412199ex10_16.htm EX-10.16 19870
6 EXHIBIT 10.17 b412199_ex10-17.htm EX-10.17 9944
7 EXHIBIT 21.1 b412199_ex21-1.htm EX-21.1 1572
8 EXHIBIT 23.1 b412199ex_23-1.htm EX-23.1 1581
9 EXHIBIT 31.1 b412199ex_31-1.htm EX-31.1 10212
10 EXHIBIT 31.2 b412199ex_31-2.htm EX-31.2 10207
11 EXHIBIT 32.1 b412199ex_32-1.htm EX-32.1 2926
12 EXHIBIT 32.2 b412199ex_32-2.htm EX-32.2 2886
  Complete submission text file 0001125282-06-001844.txt   1484255
Mailing Address ONE TOWER CENTER EAST BRUNSWICK NJ 08816
Business Address ONE TOWER CENTER EAST BRUNSWICK NJ 08816 7324189300
SAVIENT PHARMACEUTICALS INC (Filer) CIK: 0000722104 (see all company filings)

EIN.: 133033811 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-15313 | Film No.: 06715276
SIC: 2833 Medicinal Chemicals & Botanical Products